Eurofins' sales up almost 50% in the first half year of 2006
In the second quarter of 2006, Eurofins reached sales of EUR 80.7 million representing a growth of 44% compared with Q2/ 2005 (EUR 56.1 million).
Besides the organic growth, a major part of the sales increase is due to various acquisitions and outsourcing agreements carried out during the past 12 months, such as GAB Biotechnologie (Germany), LEM, Pharmacontrol, Optimed (all France), Focus Bio-Inova (France/USA), AvTech (USA), Steins (Denmark), Direct Laboratories and Agriseach (both UK).
Most read news
Organizations
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.